Clinical isolate of Citrobacter freundii highly resistant to new quinolones.
AUTOR(ES)
Aoyama, H
RESUMO
About 30% of 150 recent clinical isolates of Citrobacter freundii were resistant to greater than or equal to 3.13 micrograms of norfloxacin and ofloxacin per ml. Study of one quinolone-resistant strain for which the norfloxacin MIC was 100 micrograms/ml suggested that resistance was associated with both an altered A subunit of DNA gyrase and reduction in drug uptake accompanied by a decrease in an outer membrane protein.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=172307Documentos Relacionados
- Purification of Citrobacter freundii DNA gyrase and inhibition by quinolones.
- Carbapenem resistance in a clinical isolate of Citrobacter freundii.
- Methicillin-resistant strains of Staphylococcus aureus resistant to quinolones.
- Mycobacteria and the new quinolones.
- A new restriction endonuclease from Citrobacter freundii
